glp-1 medications overview Medications: Weight Loss & Diabetes Guide Patient education tips for GLP-1,

Results from a study examining the safety of using liraglutide in patients with moderate to severe renal impairment demonstrated no deleterious effects on serum creatinine (SCr) or increased incidence or severity of adverse events

Disclosures: Takayuki Kogure: Nothing to Disclose, Mari Satoh: Nothing to Disclose, Takehito Ito: Nothing to Disclose, Kennichi Satoh: Nothing to Disclose 1937 ACTIVATION OF COAGULATION FACTORS AND IMPAIRED FIBRINOLYSIS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND CHOLANGIOCARCINOMA Luca Fabris 1 Camilla Venturin 2 Yahima Frin-Herrera 2 Massimiliano Cadamuro 3 Claudia Mescoli 4 Umberto Cillo 2 Enrico Gringeri 2 Elena Campello 2 Mario Strazzabosco 5 Diego Calvisi 6 Antonio Cigliano 7 Paolo Simioni 2 , 1 University of Padua, Department of Medicine (DIMED), 2 University of Padua, Italy, 3 University of Milan-Bicocca, Milan, Italy, 4 Padua University-Hospital, Italy, 5 Yale University, 6 Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany, 7 Universuty of Sassari, Sassari, Italy Background: Venous thromboembolism (VTE) is the most common presentation of the cancer-associated hypercoagulable state

Call (714) 671-2005 or submit an online contact form to schedule a free consult today

Qiu Q, Cao J, Wang Y, Zhang Y, Wei Y, Hao X, et al